-
Mashup Score: 0Homepage | Progress For Patients - 2 year(s) ago
1800 M Street NW, Suite 1050 South, Washington, DC 20036 – Phone: (202) 944-6700 Friends of Cancer Research is a 501 (C)(3) non-profit organization; Our tax ID number is 52-1983273. © Copyright 2017 Friends of Cancer Research. All rights reserved.
Source: www.progressforpatients.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Homepage | Progress For Patients - 2 year(s) ago
1800 M Street NW, Suite 1050 South, Washington, DC 20036 – Phone: (202) 944-6700 Friends of Cancer Research is a 501 (C)(3) non-profit organization; Our tax ID number is 52-1983273. © Copyright 2017 Friends of Cancer Research. All rights reserved.
Source: www.progressforpatients.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Friends offers an online education program to help patients, advocates, and #caregivers acquire the tools to effectively communicate with drug researchers, developers, and regulators. Click to learn about Progress for Patients: https://t.co/pMVIqWjRfV
-
-
Mashup Score: 0Homepage | Progress For Patients - 2 year(s) ago
1800 M Street NW, Suite 1050 South, Washington, DC 20036 – Phone: (202) 944-6700 Friends of Cancer Research is a 501 (C)(3) non-profit organization; Our tax ID number is 52-1983273. © Copyright 2017 Friends of Cancer Research. All rights reserved.
Source: www.progressforpatients.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Through https://t.co/tAVdPnYWUm, Friends of Cancer Research offers an online education program to help #patients, #advocates, and #caregivers acquire the tools to effectively communicate with drug researchers, developers, and regulators. https://t.co/JY6TdHB0jf https://t.co/FDNEmvlCq7
-
-
Mashup Score: 5Homepage | Progress For Patients - 2 year(s) ago
1800 M Street NW, Suite 1050 South, Washington, DC 20036 – Phone: (202) 944-6700 Friends of Cancer Research is a 501 (C)(3) non-profit organization; Our tax ID number is 52-1983273. © Copyright 2017 Friends of Cancer Research. All rights reserved.
Source: www.progressforpatients.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
https://t.co/tAVdPnYWUm offers an online education program to help patients, advocates, and caregivers acquire the necessary tools to effectively communicate. Looking to get involved, take the course! https://t.co/aHzzLNc8fT
-
-
Mashup Score: 0Homepage | Progress For Patients - 2 year(s) ago
1800 M Street NW, Suite 1050 South, Washington, DC 20036 – Phone: (202) 944-6700 Friends of Cancer Research is a 501 (C)(3) non-profit organization; Our tax ID number is 52-1983273. © Copyright 2017 Friends of Cancer Research. All rights reserved.
Source: www.progressforpatients.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
https://t.co/tAVdPnYWUm is offering an online education program to help patients, advocates, and caregivers acquire the necessary tools to effectively communicate. Looking to get involved, take the course, and make your voice heard? https://t.co/9Rz4H8GUUq
-
-
Mashup Score: 0Homepage | Progress For Patients - 2 year(s) ago
1800 M Street NW, Suite 1050 South, Washington, DC 20036 – Phone: (202) 944-6700 Friends of Cancer Research is a 501 (C)(3) non-profit organization; Our tax ID number is 52-1983273. © Copyright 2017 Friends of Cancer Research. All rights reserved.
Source: www.progressforpatients.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Through https://t.co/tAVdPnYWUm, @CancerResrch offers an online education program to help patients, advocates, and caregivers acquire the tools to effectively communicate with drug researchers, developers, and regulators. https://t.co/yAliiuRABL
-
-
Mashup Score: 3Homepage | Progress For Patients - 2 year(s) ago
1800 M Street NW, Suite 1050 South, Washington, DC 20036 – Phone: (202) 944-6700 Friends of Cancer Research is a 501 (C)(3) non-profit organization; Our tax ID number is 52-1983273. © Copyright 2017 Friends of Cancer Research. All rights reserved.
Source: www.progressforpatients.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
"https://t.co/2z5akT02sn has educated over 500 patients and their advocates on the @US_FDA drug development process." @CancerResrch Vice President Ryan Hohman discussing https://t.co/2z5akT02sn at todays @NIH NCRA meeting https://t.co/ADh818HTxl https://t.co/wp42N23sFD
-
"Our goal all along has been to empower patients. It’s essential we ensure they feel fully equipped before entering into a clinical trial.” @CancerResrch Vice President Ryan Hohman live @NIH NCRA meeting discussing https://t.co/2z5akT02sn https://t.co/0ENqlfZSMG https://t.co/N6ZrEp8UkR
-
-
Mashup Score: 0Homepage | Progress For Patients - 2 year(s) ago
1800 M Street NW, Suite 1050 South, Washington, DC 20036 – Phone: (202) 944-6700 Friends of Cancer Research is a 501 (C)(3) non-profit organization; Our tax ID number is 52-1983273. © Copyright 2017 Friends of Cancer Research. All rights reserved.
Source: www.progressforpatients.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
https://t.co/tAVdPnYWUm is an online education program to help patients, advocates, and caregivers learn about drug development to acquire the necessary tools to work with drug researchers, developers, and regulators. https://t.co/eciPHwkvqo
-
-
Mashup Score: 0Homepage | Progress For Patients - 4 year(s) ago
1800 M Street NW, Suite 1050 South, Washington, DC 20036 – Phone: (202) 944-6700 Friends of Cancer Research is a 501 (C)(3) non-profit organization; Our tax ID number is 52-1983273. © Copyright 2017 Friends of Cancer Research. All rights reserved.
Source: www.progressforpatients.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
https://t.co/tAVdPnYWUm: An at-home patient advocacy learning experience when we need it most. Get started now with free instant access using code "learnathome" - https://t.co/rrozMr6gWa #ProgressForPatients https://t.co/kDQyXjyYw0
-
Through https://t.co/tAVdPnYWUm, @CancerResrch offers an online education program to help #patients, #advocates, and #caregivers acquire the tools to effectively communicate with drug researchers, developers, and regulators. https://t.co/KWlAqoivNh